Status:
COMPLETED
Safety Evaluation of Intranasal Use of DSM 32444 Postbiotic in Humans
Lead Sponsor:
Huro Biotech Joint Stock Company
Collaborating Sponsors:
Thai Binh University of Medicine and Pharmacy
Conditions:
Rhino Sinusitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rhinitis is a type of upper respiratory infection with a common nasal pathology especially in Southeast Asia, which is characterized by the presence of one or more of the following symptoms: itchy nos...
Detailed Description
Rhinitis is a type of upper respiratory infection and a common nasal pathology especially in Southeast Asia, which is characterized by the presence of one or more of the following symptoms: itchy nose...
Eligibility Criteria
Inclusion
- Healthy volunteers must be ≥18 years of age, at the time of signing the informed consent.
- Participants who are able to use an e-Diary or Paper Diary during the study to report their health status
- Participants capable of giving a signed informed consent form (ICF)
Exclusion
- Planned travel outside of the study area during the study period.
- Use of any investigational drug within 30 days prior to Day screening. No investigational products are permitted for use during the conduct of this study
- A known history of alcohol or drug abuse within the last 2 years
- Existence of any medical condition, which in the opinion of the investigator, might significantly affect the subject's ability to complete this trial; or their safety in this trial
Key Trial Info
Start Date :
September 26 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 20 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05984004
Start Date
September 26 2022
End Date
April 20 2023
Last Update
April 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thai Binh University of Medicine and Pharmacy
Thái Bình, Thai Binh, Vietnam